Muestra la distribución de su producción desde 2008 por disciplinas.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Institución | Hosp Exequiel Gonzalez Cortes |
| WOS | #Pub |
|---|---|
| Pediatrics | 52 |
| Infectious Diseases | 26 |
| Urology & Nephrology | 11 |
| Hematology | 10 |
| Oncology | 10 |
| Endocrinology & Metabolism | 9 |
| Immunology | 7 |
| Surgery | 6 |
| Dermatology | 5 |
| Clinical Neurology | 4 |
| Transplantation | 3 |
| Orthopedics | 3 |
| Medicine, General & Internal | 3 |
| Critical Care Medicine | 2 |
| Health Care Sciences & Services | 2 |
| Nutrition & Dietetics | 2 |
| Health Policy & Services | 1 |
| Allergy | 1 |
| Economics | 1 |
| Medicine, Research & Experimental | 1 |
| Primary Health Care | 1 |
| Rehabilitation | 1 |
| Virology | 1 |
| Pharmacology & Pharmacy | 1 |
| Genetics & Heredity | 1 |
| Gastroenterology & Hepatology | 1 |
| Biochemistry & Molecular Biology | 1 |
| Obstetrics & Gynecology | 1 |
| Radiology, Nuclear Medicine & Medical Imaging | 1 |
| Nursing | 1 |
| Public, Environmental & Occupational Health | 1 |
| Dentistry, Oral Surgery & Medicine | 1 |
| Scopus | #Pub |
|---|---|
| Infectious Diseases | 26 |
| Public Health, Environmental And Occupational Health | 23 |
| Pediatrics, Perinatology And Child Health | 21 |
| Urology | 6 |
| Medicine (All) | 3 |
| Microbiology (Medical) | 3 |
| Critical Care And Intensive Care Medicine | 2 |
| Family Practice | 1 |
| Endocrinology | 1 |
| Immunology And Allergy | 1 |
| Hematology | 1 |
| Genetics (Clinical) | 1 |
| Cancer Research | 1 |
| Oncology | 1 |
| Endocrinology, Diabetes And Metabolism | 1 |
| Genetics | 1 |
| Obstetrics And Gynecology | 1 |
| Surgery | 1 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 33 |
| Biological Sciences | 8 |
| Publicaciones | Citas | ||||
|---|---|---|---|---|---|
| Total | Porcentaje | Total | Porcentaje | Representativas Cuartil (Mediana) | |
| Q1 | 19 | 19.8 % | 76 | 18.7 % | 5.5 |
| Q2 | 22 | 22.9 % | 163 | 40.1 % | 8.0 |
| Q3 | 19 | 19.8 % | 86 | 21.2 % | 6 |
| Q4 | 36 | 37.5 % | 81 | 20.0 % | 3.0 |